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Abstract
Background: In acute-care hospitals, no evidence of a protective effect of healthcare worker (HCW) vaccination on
hospital-acquired influenza (HAI) in patients has been documented. Our study objective was to ascertain the
effectiveness of influenza vaccination of HCW on HAI among patients.
Methods: A nested case-control investigation was implemented in a prospective surveillance study of influenza-like
illness (ILI) in a tertiary acute-care university hospital. Cases were patients with virologically-confirmed influenza
occurring ≥ 72 h after admission, and controls were patients with ILI presenting during hospitalisation with
negative influenza results after nasal swab testing. Four controls per case, matched per influenza season (2004-05,
2005-06 and 2006-07), were randomly selected. Univariate and multivariate conditional logistic regression models
were fitted to assess factors associated with HAI among patients.
Results: In total, among 55 patients analysed, 11 (20%) had laboratory-confirmed HAI. The median HCW
vaccination rate in the units was 36%. The median proportion of vaccinated HCW in these units was 11.5% for
cases vs. 36.1% for the controls (P = 0.11); 2 (20%) cases and 21 (48%) controls were vaccinated against influenza in
the current season (P = 0.16). The proportion of ≥ 35% vaccinated HCW in short-stay units appeared to protect
against HAI among patients (odds ratio = 0.07; 95% confidence interval 0.005-0.98), independently of patient age,
influenza season and potential influenza source in the units.
Conclusions: Our observational study indicates a shielding effect of more than 35% of vaccinated HCW on HAI
among patients in acute-care units. Investigations, such as controlled clinical trials, are needed to validate the
benefits of HCW vaccination on HAI incidence in patients.
Background
Hospital-acquired influenza (HAI) is associated with sig-
nificant morbidity and mortality in hospitalised patients
[1]. Prevention and control of nosocomial influenza
entail multiple measures; vaccination of healthcare
workers (HCW) is advocated by the Centers for Disease
Control and Prevention to obviate influenza transmis-
sion in healthcare settings [2]. Influenza vaccine
coverage of HCW remains low despite these recommen-
dations [3], indicating that additional data are needed to
establish the benefits of vaccination and promote it
among HCW.
No evidence of a protective effect of HCW vaccination
on proven HAI in patients has been reported. Indeed,
the efficacy of HCW vaccination in preventing influenza
among patients in long-term care hospitals was not
found in a systematic review by Thomas et al. [4] in
2006. Earlier, 2 randomised clinical trials [5,6] disclosed
reductions in overall mortality and influenza-like illness
(ILI) among elderly patients after HCW vaccination
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However, data are sparse in acute-care settings. Studies
in long-term institutions were conducted to assess the
effectiveness of flu vaccination in preventing disease
spread among elderly populations residing in care facil-
ities [4-6]. These settings differed from those in acute-
care hospitals in terms of population, care and contact
patterns.
Despite such conclusions, HCW vaccination is
expected to actually have a protective influence. Simula-
tion studies have shown that HCW vaccination is effec-
tive and that its proportion is linked linearly to the
influenza attack rate in nursing homes [7] as well as in
acute-care hospitals [8]. Clinical trials are the gold stan-
dard for addressing this issue, but their results are not
conclusive [4-6]. Clustered, randomised trials are diffi-
cult to conduct in acute-care hospitals because of rapid
patient turnover.
The objective of our observational investigation was to
ascertain the effectiveness of influenza vaccination of
HCW on laboratory-confirmed HAI among patients.
Methods
Setting
Data were extracted from a hospital-based, prospective
surveillance study of ILI detailed elsewhere [9]. Briefly,
this prospective surveillance study enrolled all ILI
patients hospitalised between October 15 and April 15
in 2004-05, 2005-06 and 2006-07, in Edouard Herriot
Hospital (Lyon, France), a tertiary, acute-care university
hospital with 1,000 beds. Totally, 36 (84%) of the hospi-
tal’s 43 adult short-stay units participated on a voluntary
basis: 12 with 224 beds in 2004-05, 29 with 493 beds in
2005-06, and 30 with 537 beds in 2006-07. No specific
infection transmission control measures were implemen-
ted during the study period. Standard procedures were
followed throughout the hospital, with droplet precau-
tions in case of ILI. Once a day, research nurses con-
tacted participating units to search for new patients
with ILI, defined as rectal or axillary temperature ≥ 37.8
C, in the absence of antipyretics, with cough or sore
throat [10]. All incident cases of ILI during hospital stay
were included. At ILI diagnosis, the following variables
were analysed: date of admission and discharge, underly-
ing diseases, start and end dates of clinical ILI features,
potential sources of exposure to influenza within 5 days
before ILI or influenza occurrence, outcome, influenza
vaccination status and vaccination date. On the day of
ILI suspicion, nasal swab testing served to confirm influ-
enza in cases and controls. When incident ILI was
detected (in patients or HCW), a research nurse visited
the unit twice daily to document case follow-up and to
find secondary cases, which were included in the sur-
veillance according to clinical criteria similar to those
for other ILIs. Each secondary ILI case was followed as
an incident case, and the whole unit was monitored for
10 days after incident case onset to detect secondary
cases. A potential influenza source was defined as the
presence of at least 1 person with ILI (patient or HCW)
in the units considered as being contagious, within 5
days before onset-from 1 day preceding ILI to 4 days
thereafter.
A nested case-control investigation was conducted in
this prospective surveillance study of hospital-acquired
ILI [9]. Cases were patients with virologically-confirmed
influenza occurring ≥ 72 h after admission in acute-stay
units [1]. Controls were patients with ILI during hospi-
talisation with negative influenza results after nasal swab
testing. Four controls per case, matched per influenza
season (2004-05, 2005-06 and 2006-07), were randomly
selected among all eligible controls. The exposure of
interest was the proportion of HCW vaccinated against
influenza in these units, collected prospectively by the
occupational health department of the hospital. HCW
vaccination was confirmed by occupational health
department data. All HCW categories were included:
physicians, nursing staff, ancillary and allied health staff.
The proportion of vaccinated HCW was dichotomised
according to the median of its distribution. Potential
confounders were gender, likely sources of influenza in
the same ward (other patients or HCW) within 5 days
before influenza or another ILI occurrence during hospi-
tal stay, individual patient vaccination against influenza,
type of ward, and underlying disease. Clinical suspicion
of influenza was based on the above definition.
Virological tests
All cases and controls underwent similar nasal swab
testing by the Centre national de référence des virus
influenza région Sud in Lyon. Specimens were analysed
for influenza virus by immuno-capture ELISA, immuno-
staining, tissue cell culture, and polymerase chain reac-
tion. Sample suspensions were inoculated into Madin-
Darby canine kidney cells, epithelial Hep-2 cells and
fibroblastic MRC-5 cells. The number of HCW and vac-
cinated HCW per participating unit as well as per year
was recorded prospectively.
Statistical analysis
Categorical variables were compared by Fisher’s exact
test, and continuous variables, by the Mann-Whitney U-
test. Conditional logistic regression was undertaken to
assess factors associated independently with HAI among
patients. Covariates with P < 0.15 after univariate analy-
sis as well as gender and age were entered into the
initial multivariate model, backward step-wise regression
analysis was conducted, and the likelihood ratio test
compared models until P < 0.15. Potential interactions
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All tests were 2-tailed, and P < 0.05 was considered sig-
n i f i c a n t .T h ed a t aw e r ea n a l y s e db yS t a t as o f t w a r e8 . 0
(StataCorp LP 2003, College Station, TX). The protocol
design was approved by the hospital’s institutional
review board. All patients received study information
and gave signed, informed consent.
Results
Population characteristics
Among 55 patients analysed overall, 11 (20%) had labora-
tory-confirmed HAI. Median age was 77.3 years, and 41
(75%) were female. Totally, 13 (23%) were hospitalised in
a medical unit, 8 (15%) in a surgical unit, 8 (15%) in an
obstetrics-gynaecology unit, 26 (47%) in a short-term
elderly patient unit, and none in an intensive care unit.
Seven (13%) had chronic pulmonary disease, 26 (47%)
had chronic cardiac disease, and 2 (4%) were immuno-
compromised. One patient died during hospitalisation
(unrelated to influenza). Twenty (36%) patients had at
least 1 potential patient or HCW source of influenza
infection in the same ward within 5 days before ILI or
influenza occurrence. The median HCW vaccination rate
in the units was 36% (0% to 67%) with a mean of 34%.
Factors associated with HAI among patients
Figure 1 shows the repartition of cases and controls
according to HCW vaccination rates in the units. The
median proportion of vaccinated HCW in these units
was 11.5% for cases vs. 36.1% for the controls (P =
0.11). After univariate analysis (Table 1), the presence of
at least 1 influenza source in the ward increased the risk
of HAI. After multivariate analysis (Table 2), a propor-
tion of vaccinated HCW of more than 35% in the units,
compared to a lower proportion, was protective against
laboratory-confirmed HAI among patients (odds ratio =
0.07; 95% confidence interval 0.005-0.98), after adjusting
for age and the presence of potential influenza sources
in the units.
Discussion
The study objective was to assess the effectiveness of
influenza vaccination of HCW on laboratory-confirmed
HAI among patients based on prospectively-collected
observational data. Our results indicate that a propor-
tion of vaccinated HCW of more than 35% in short-stay
units, in comparison to a lower proportion, was protec-
tive against laboratory-confirmed HAI among patients,
independently of flu season, patient age, and the pre-
sence of a potential influenza source.
Simulations have shown that HCW vaccination is
effective against influenza in patients from nursing
homes or in acute-care settings, but have provided no
evidence of a threshold decrease in the influenza attack
rate with increasing HCW vaccination proportion [6,7].
In our investigation, because of its small sample size, we
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Figure 1 Repartition of cases and controls according to the proportion of vaccinated healthcare workers in short-stay units of
Edouard Herriot Hospital, Lyon (France), in influenza seasons 2004-05, 2005-06 and 2006-07.
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ship (Figure 1). The threshold that we reported was
based on the distribution of HCW vaccination in our
hospital. A proportion of vaccinated HCW of less than
35% seemed to have no effect on HAI in patients,
whereas a proportion of more than 35% could be con-
sidered, according to our data, as the minimal vaccina-
tion coverage with potential protective impact on
hospital-acquired incident cases. This result discloses
the difficulties encountered in quantifying the influence
of vaccination in clinical trials without taking different
HCW vaccination proportions into account. Moreover,
1 simulation study reported an unexpected absence of
herd immunity against influenza in nursing homes,
implying that the vaccination of every additional HCW
protected an additional fraction of patients [7]. Also,
while a higher proportion of vaccinated HCW is
expected, it has not been demonstrated that the concept
of herd immunity, which needs large and closed popula-
tions, can be applied in acute-care settings with multiple
different contacts.
Our study had some strengths. It was prospective,
with case definition based on laboratory-confirmed
influenza and standardised definitions regarding the
delay to hospital acquisition [1] as well as virological
testing of all controls. Also, HAI could be difficult to
diagnose. Our study allowed us to analyse the effective-
ness of a vaccination strategy, whereas clinical trials
with such an objective would have to be very large (i.e.,
for simulation, 169 departments per arm would be
needed) [7]. Simonsen et al. proposed case-control stu-
dies with highly-specific endpoints, such as laboratory-
confirmed influenza [11]. We attempted to provide
more arguments to a question that remains to be
answered, namely: does influenza vaccination of HCW
have an impact on the occurrence of hospital-acquired,
virologically-proven influenza among patients in acute-
Table 1 Characteristics of the controls and patients with laboratory-confirmed, hospital-acquired influenza (HAI) and
of the factors associated with HAI in Edouard Herriot Hospital, Lyon (France), in influenza seasons 2004-05, 2005-06
and 2006-07
Characteristics Patients with confirmed HAI (N = 11) Controls (N = 44) P Crude OR
a (95% CI)
Gender, female 8 (73) 33 (75) 1.0 0.89 (0.22-3.72)
Age, years 0.99 (0.97-1.02)
b
Median (range) 66.0 (48.5-85.1) 78.7 (42.3-86.7) 0.6
Type of ward 1.0
Medicine 8 (73) 31 (70) 1.0 (Ref.)
Surgery 3 (27) 13 (30) 0.90 (0.21-3.89)
Chronic pulmonary disease 2 (18) 5 (11) 0.6 1.60 (0.31-8.25)
Chronic cardiac disease 5 (45) 21 (48) 1.0 0.92 (0.26-3.28)
Immuno-depression 2 (18) 1 (2) 0.10 8.00 (0.73-88.22)
Potential influenza source in the unit
c 7 (64) 13 (30) 0.08 4.06 (1.08-15.33)
Individual influenza vaccination
d, e 2 (20) 21 (48) 0.16 0.34 (0.069-1.70)
Proportion of vaccinated HCW in the unit 0.10
< 35% 8 (73) 19 (43) 1.0 (Ref.)
≥ 35% 3 (27) 25 (57) 0.16 (0.018-1.32)
Data are reported as numbers (%) under descriptive analysis and as OR (95% CI) under logistic regression analysis. Controls were hospitalised patients with ILI
and confirmed exclusion of influenza diagnosis after nasal swabbing; they were matched by influenza season (2004-05, 2005-06 and 2006-07). HAI, hospital-
acquired influenza; OR, odds ratio; CI, confidence interval; HCW, healthcare workers.
aUnder univariate conditional logistic regression
bPer 1 year older
cPotential sources of exposure to influenza (other patients or HCW) for 5 days before ILI or influenza occurrence in the same ward
dIn current influenza season
eIndividual influenza vaccination was not known in 1 patient
Table 2 Factors associated independently with hospital-
acquired influenza among patients in Edouard Herriot
Hospital, Lyon (France), in influenza seasons 2004-05,
2005-06 and 2006-07
Characteristics Adjusted OR
a (95% CI)
Age, per 1 year older 1.03 (0.99-1.07)
Potential influenza source in the unit
b 5.22 (1.08-25.22)
Proportion of vaccinated HCW in the unit
< 35% 1.0 (Ref.)
≥ 35% 0.07 (0.005-0.98)
OR, odds ratio; CI, confidence interval; HCW, healthcare workers.
aMultivariate conditional logistic regression, adjusted on the other covariates
bPotential sources of exposure to influenza (other patients or HCW) for 5 days
before ILI or influenza occurrence in the same ward
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text of flu pandemics and even seasonal epidemics in
healthcare settings. The experimental design for obtain-
ing a definitive answer might be difficult to implement.
Thus, convergent results from observational studies
would be helpful for infection control professionals [12].
Our study design also had limitations. The main lim-
itations were the classification bias of exposure and the
balance of confounders. Other limitations must be
emphasized. First, the number of cases was small
because our case definition was restrictive, which con-
strained our study’s power. However, the misclassifica-
tion bias of cases and controls must have been low
because all controls were tested for influenza virus. Sec-
ond, it is possible that units where a higher proportion
of HCW are vaccinated are also units where high stan-
dards of respiratory hygiene and infection control prac-
tices are respected, and could be important in reducing
the risk of nosocomial influenza transmission. However,
our investigation was observational, and no additional
specific measure was formally implemented because of
the study. Finally, exposures of hospitalised patients to
visitors were not recorded. They may constitute another
non-assessed source of exposure to influenza.
Conclusions
In summary, our observational study indicates a protec-
tive influence of vaccination of more than 35% of HCW
on HAI in patients. Other experimentally-designed
investigations are needed to demonstrate the effective-
ness of HCW vaccination in the control of influenza
outbreaks in healthcare settings, and to determine the
threshold for vaccinated HCW proportion with more
accuracy [13]. Our findings must not be misinterpreted.
To date, the HCW vaccination rate of 35% is not opti-
mal to control HAI. Higher vaccination coverage among
HCW with strict adherence to recommended infection
control measures is warranted, including the screening
of visitors and HCW for illnesses suggestive of influ-
enza, the restriction of those with any symptoms from
the hospital, the use of neuraminidase inhibitors for the
treatment of cases and for the chemoprophylaxis of
exposed patients as well as non-vaccinated HCW.
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